Portfolio governance workspace
Main app
A cleaner working surface for TRI, risk, and milestone discipline.
The app now looks less like placeholder marketing and more like an institutional operating view: portfolio stats, prioritized reviews, and program-level translational signals.
Programs
24
active programs under portfolio governance
At risk
9
programs missing core translational evidence
Ready now
5
candidates fit for acceleration or diligence packaging
Board packets
3
reviews that need committee-ready output this week
Portfolio snapshot
Programs requiring institutional attention
This is the first useful surface: enough structure to orient, diagnose, and decide what needs review next.
Program Owner TRI Status
OncoPatch Dx
Clinical and technical readiness are improving, but IP package is incomplete.
Duke-NUS translational office
68
Needs governance closure
CardioSense AI
Budget-to-milestone progress is lagging and regulatory narrative is still thin.
Grant portfolio - continuation review
54
Stage-gate at risk
NeoLiver Platform
Strong technical and commercial signals; governance package needs tightening before outreach.
Investor diligence queue
77
Acceleration candidate
Priority queue
Next product workflows to build properly
These cards map directly to the next build phase: evidence intake, governance completion, and institutional review output.
Committee packet
Prepare structured continuation review pack
Bundle TRI, risk heatmap, milestone drift, and mitigation guidance for 3 programs due this week.
Governance completion
Close missing evidence artifacts
Surface absent regulatory, IP, and commercialization files before the next institutional review cycle.
Portfolio action
Identify acceleration-ready programs
Separate governance-clean opportunities from programs that still need internal de-risking.